Maxwellia Ltd

A pioneering British company building consumer healthcare brands for effective self-care.

Maxwellia is a trailblazing consumer healthcare company that specialises in turning proven prescription drugs into household medicine brands through a regulatory process known as 'switching'. As the only company in the UK dedicated to this, Maxwellia is a leader in the field, offering consumers easier access to trusted medications without needing a doctor’s appointment or prescription.


Over the past 12 months, Maxwellia has transformed from a one-brand start-up to a scale-up powerhouse with a portfolio of four innovative women’s health brands. These brands are now stocked by some of the UK’s largest pharmacy chains, including Boots, Superdrug, Tesco, and Asda. With 3x revenue growth year-on-year and a qualified pipeline of innovative products, Maxwellia continues to push the boundaries of consumer healthcare.

The UK OTC market is booming, set to reach £4bn by 2030 (1), and with calls for a renewed focus on medicine reclassification to support the over-stretched NHS (2), the time is ripe for innovating in self-care. With a lean yet highly skilled team, Maxwellia has proven its ability to turn ambition into tangible results, and is ready to deliver its next stage of explosive growth.

Currently raising funds via KickStart Capital.

Healthcare Medtech